US2019275077A1PendingUtilityA1

Hypochlorous acid-based hand sanitizer

Assignee: Reoxcyn LLCPriority: Sep 15, 2016Filed: Sep 27, 2018Published: Sep 12, 2019
Est. expirySep 15, 2036(~10.1 yrs left)· nominal 20-yr term from priority
C11D 3/3734A61K 8/25C11D 3/1266A61Q 19/10A61K 8/24C11D 3/373A61Q 17/005C11D 7/02A61K 8/585A01N 59/00C11D 3/3958A61K 8/891A61K 8/20A61K 33/20A61K 47/34A61K 47/02Y02A50/473Y02A50/481Y02A50/30
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A sanitizing formulation is disclosed for use as a hand sanitizer. The formulation may include hypochlorous acid, a silicone polymer or blend thereof, sodium phosphate, hydrochloric acid, and sodium magnesium silicate. Methods of using and making the sanitizing formulation are also disclosed.

Claims

exact text as granted — not AI-modified
1 . A method of disinfecting a surface, comprising:
 applying to the surface a sanitizing formulation comprising:
 hypochlorite, 
 at least one of sodium phosphate or hydrochloric acid, 
 sodium magnesium silicate, and 
 a silicone polymer or blend thereof. 
   
     
     
         2 . The method of  claim 1 , wherein the surface is skin. 
     
     
         3 . (canceled) 
     
     
         4 . The method of  claim 1 , wherein hypochlorite is in an amount of about 75 ppm, wherein the sodium phosphate is in an amount of about 0.2% w/v, wherein the hydrochloric acid is in an amount of about 0.08% w/v, wherein the sodium magnesium silicate is in an amount of about 3% w/v, and wherein the silicone polymer or blend thereof is in an amount of about 3% w/v. 
     
     
         5 . The method of  claim 1 , wherein the sanitizing formulation further comprises water, buffer, or combinations thereof. 
     
     
         6 . The method of  claim 1 , wherein the applying comprises killing at least one superbug. 
     
     
         7 . The method of  claim 6 , wherein the at least one superbug is selected from the group consisting of  Staphylococcus aureus  (including methicillin-resistant  S. aureus  (MRSA) and vancomycin-resistant  S. aureus  (VRSA)), extended spectrum beta-lactamase (ESBL),  Pseudomonas aeruginosa, Clostridium difficile, Salmonella, Mycobacterium tuberculosis, Escherichia coli  (including Carbapenem resistant  E. coli ), multidrug-resistant  Acinetobacter baumannii  (MRAB), vancomycin-resistant  Enterococcus  (VRE), Carbapenem resistant  Klebsiella pneumoniae,  HIV, hepatitis, and influenza. 
     
     
         8 . A sanitizing formulation, comprising:
 hypochlorous acid;   sodium phosphate or hydrochloric acid;   sodium magnesium silicate; and   a silicone polymer or blend thereof.   
     
     
         9 - 18 . (canceled) 
     
     
         19 . A method for treating an irritation or discomfort in a genital area, the method comprising:
 providing a lubricant comprising hypochlorite, an emulsifier comprising sodium magnesium silicate, and a silicone polymer; and   applying the lubricant to an irritation or discomfort in a genital area.   
     
     
         20 . A method for inhibiting a microbial infection, the method comprising:
 providing a lubricant comprising hypochlorite, an emulsifier comprising sodium magnesium silicate, and a silicone polymer; and   applying the lubricant to a microbial infection.   
     
     
         21 . A system for healing a wound, comprising:
 a wound dressing material impregnated with an electrolyzed saline formulation, wherein the wound is a burn,   the electrolyzed saline formulation comprising:
 reactive oxygen species comprising hypochlorite and superoxides; 
 a buffer; 
 a rheology agent; and 
 a silicone polymer or blend thereof. 
   
     
     
         22 . A method of treating a burn on an individual, the method comprising:
 topically applying an electrolyzed saline formulation to the burn, wherein the electrolyzed saline formulation comprises:
 hypochlorite; 
 superoxides of *O 2   −  and HO 2 ; 
 sodium phosphate; 
 sodium magnesium silicate; and 
 dimethicone. 
   
     
     
         23 . A method of treating a wound in a subject afflicted with a wound, the method comprising:
 applying to a wound an electrolyzed saline formulation comprising:
 hypochlorite; 
 superoxides of *O 2   −  and HO 2 ; 
 a buffer; 
 a rheology agent; and 
 a silicone polymer or blend thereof. 
   
     
     
         24 . A personal lubricant, comprising hypochlorite, an emulsifier comprising sodium magnesium silicate, a silicone polymer and a buffer. 
     
     
         25 . A method of sanitizing hands, comprising applying to a user's hands a sanitizing formulation comprising hypochlorous acid. 
     
     
         26 . A method of making a sanitizing formulation, comprising mixing a hypochlorite solution with a silicone polymer or blend thereof to form a sanitizing formulation. 
     
     
         27 . A kit, comprising:
 a lubricant; and   a condom,   wherein the lubricant comprises hypochlorite, an emulsifier, a silicone polymer, and a buffer.   
     
     
         28 . A method of making a wound healing formulation, comprising mixing a hypochlorite solution with a silicone polymer or blend thereof to form the wound healing formulation. 
     
     
         29 . A wound healing formulation, comprising hypochlorite, a buffer, a rheology agent and a silicone polymer or blend thereof.

Join the waitlist — get patent alerts

Track US2019275077A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.